Join Now My Chatterbean
 
Home > Articles > Health > Skin > Pediatric dermatitis: Efalizumab succeeds where standard treatments fail
health

Pediatric Dermatitis: Efalizumab Succeeds Where Standard Treatments Fail

The biologic agent efalizumab, most commonly used to treat moderate-to-severe plaque psoriasis, may be effective in the treatment of severe atopic dermatitis. Dermatologist Roman Minano, M.D., says that efalizumab may be considered when other therapeutic approaches have failed. A case study is outlined in which efalizumab has totally cleared a patient's atopic dermatitis.

Read Full Article

More Skin Articles

Acne
Soy Eaten In Whole, Unrefined Forms Is Preferable
Research On Skin Bacteria Sets New Treatments In Motion
Health Tip: Wear Sunscreen, Even If You Don't Burn
5 Surprising Ways To Sun-Proof Your Skin
Rosacea: Causes Of And Coping With The Dreaded Red
Health And Beauty: Battling Back Against Eczema
UCSD Pits Herpes Against Melanoma
Mouse Gene Aids Allergy Research
Molecular Structure Could Help Explain Albinism, Melanoma
Advertisement


 
Not a member? Join now. Membership is free and packed with perks.